RhumbLine Advisers’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $180K | Buy |
|
|||||
|
2025
Q2 | $267K | Buy |
|
|||||
|
2025
Q1 | $198K | Buy |
|
|||||
|
2024
Q4 | $231K | Buy |
|
|||||
|
2024
Q3 | $114K | Sell |
|
|||||
|
2024
Q2 | $102K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $115K | Sell |
|
|||||
|
2021
Q4 | $280K | Sell |
|
|||||
|
2021
Q3 | $317K | Buy |
|
|||||
|
2021
Q2 | $304K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $43K | Buy |
|
|||||
|
2016
Q4 | $52K | Sell |
|
|||||
|
2016
Q3 | $179K | Buy |
|
|||||
|
2016
Q2 | $177K | Buy |
|
|||||
|
2016
Q1 | $131K | Buy |
|
|||||
|
2015
Q4 | $147K | Buy |
|
|||||
|
2015
Q3 | $130K | Buy |
|
|||||
|
2015
Q2 | $206K | Buy |
|